The serotonin transporter (SERT) regulates serotonergic neurotransmission by retrieving released serotonin and replenishing vesicular stores. SERT is not only delivered to axons but it is also present on the neuronal soma and on dendrites. It has not been possible to restrict the distribution of SERT without affecting transporter function. Hence, the physiological role of somatodendritic SERT remains enigmatic. The SERT C-terminus harbors a conserved RI-motif, which recruits SEC24C, a cargo receptor in the coatomer protein-II coat. Failure to engage SEC24C precludes axonal enrichment of SERT. Here we introduced a point mutation into the RI-motif of human SERT causing confinement of the resulting -otherwise fully functional -hSERT-R 607 A on the somatodendritic membrane of primary rat dorsal raphe neurons. Transgenic expression of the corresponding Drosophila mutant dSERT-R
Introduction
In the brain, the monoamines serotonin, noradrenaline and dopamine act as neuromodulators; monoaminergic axons originate from small clusters of neurons, elaborate complex arborizations and project diffusely to reach many neurons. This is exemplified by serotonergic projections, which originate from the midbrain and pontine raphe nuclei, and are found in virtually the entire mammalian brain. Serotonin released from these axonal projections is retrieved by the serotonin transporter (SERT) a member of the solute carrier-6 (SLC6) family (SLC6A4). SERT is the target for both, therapeutic and recreational drugs: inhibition of SERT by selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs) is the basis for their eponymous action in depression and related mood disorders. Reverse transport and the resulting serotonin release underlie the action of methylene-dioxyamphetamine (MDMA/ecstasy) and related congeners https://doi.org/10.1016/j.neuropharm.2019.03.007 Received 21 November 2018; Received in revised form 11 February 2019; Accepted 3 March 2019 . SERT is not only found on the axolemma; circumstantial evidence suggested that it was also present on the cell bodies of raphe neurons (Dewar et al., 1991) . This was confirmed by electron microscopy: SERT was visualized on the somatodendritic surface (Pickel and Chan, 1999; Tao-Cheng and Zhou, 1999) , which raised the question of its physiological relevance.
Axonal delivery of neurotransmitter transporters of the family SLC6 is contingent on export from the endoplasmic reticulum via the recruitment of the coatomer protein II (COPII) coat: the C-terminus of neurotransmitter transporter harbors an RL/RI-motif, which specifies their interaction with SEC24C or SEC24D, the cargo receptor of the COPII coat (Farhan et al., 2007; Sucic et al., 2011 Sucic et al., , 2013 . Mutations in the RL/RI-motif of the transporter or in the cargo binding site of cognate SEC24 isoform results in somatodendritic confinement of the GABA-transporter-1 (GAT1/SLC6A1) (Reiterer et al., 2008) and of SERT (Montgomery et al., 2014) . The physiological role of SERT located in the somatodendritic compartment is poorly understood, but it has been proposed to play an important role in the action of antidepressants (Colgan et al., 2012) .
Here, we addressed the physiological role of SERT in the somatodendritic compartment using the serotonergic system of Drosophila. The RI/RL-motif is conserved in most eukaryotic SLC6 transporters and present in the serotonin transporter of Drosophila melanogaster (dSERT). Flies also rely on orthologs of the COPII machinery, namely SEC23, SEC24AB, SEC24CD and SAR1 (Tsarouhas et al., 2007; Förster et al., 2010; Norum et al., 2010) to support the ER export of natively folded membrane proteins . The adult brain of Drosophila contains about 80 serotonergic neurons organized in distinct cell clusters, which are involved in modulating the circuitry underlying e.g. the circadian rhythm, feeding, aggression and long-term memory formation (Kasture et al., 2018) . Furthermore, modulation of SERT expression in a subset of serotonergic neurons affects odor perception in adult flies (Xu et al., 2016) . Accordingly, we introduced a point mutation in dSERT and verified that the resulting mutant dSERT-R 599 A was enriched in the somatodendritic compartment of serotonergic neurons in the Drosophila brain. This experimental approach allowed for exploring the compartment-specific role of SERT in an in vivo context. (47.5 Ci/mmol) were obtained from PerkinElmer Life Sciences. Cell culture reagents, supplement and antibiotics were purchased from Invitrogen. Complete™ protease inhibitor mixture and bovine serum albumin (BSA) were obtained from Roche Applied Science (Mannheim, Germany). Glial-derived neurotrophic factor was purchased from Millipore. Scintillation mixture (Rotiszint ® eco plus) and TRIS were from Carl Roth GmbH (Karlsruhe, Germany); SDS was obtained from.
Materials and Methods

Reagents -
BioMol GmbH (Hamburg, Germany). Rabbit Anti-GFP antibody was from Abcam Plc (Cambridge, UK), NCAD from Developmental Studies Hybridoma Bank (DSHB), University of Iowa, USA. All other chemicals were of analytical grade. The dSERT construct was provided by Dr. Susan G. Amara (Laboratory of Molecular and Cellular Neurobiology, National Institute of Mental Health, USA). pUAS-N-mCherry-BD-attB vector was obtained from DGRC. For knock-down of SEC24C, stealth RNA duplex oligoribonucleotides SEC24CHSS114388, SEC24CHSS1-14389, and SEC24CHSS114390 were ordered from Invitrogen. pUASTattB vector was generously provided by Drs Bischof and Basler, University of Zurich. Citalopram hydrobromide (PH1640-1G) was obtained from Sigma-Aldrich, Vienna, Austria.
Drosophila genetics -YFP-tagged dSERT and dSERT-R
599
A were inserted into the pUAST-attB vector. The constructs were injected into embryos from M{vas-int.Dm}ZH-2A,M{3xP3-RFP.attP0}ZH-86Fb (Bloomington stock no 24749). In addition, dSERT-R
A was also inserted into pUAS-N-mCherry-BD-attB; the vector was injected along with helper plasmid into embryo of w 1118 . Positive transformants were isolated and selected. All flies were kept at 25°C and all crosses were performed at 25°C. TRH-GAL4 was kindly provided by Hiromu Tanimoto, Tohoku University, Japan. CSD-GAL4 (Bloomington drosophila stock center ID: 49377; R37D04 GAL4), SERT mutant (Bloomington drosophila stock center ID: 36004) were obtained from Bloomington Drosophila stock center, Indiana University. Behavioral assays were performed in SERT mutant background. All transgenic fly lines were isogenized by crossing with balancer flies (Bloomington stock no. 3704).
Cell culture and transfections -HEK293 and CAD cells were cultured at 37°C in a 5% CO 2 , in Dulbecco's modified Eagle's medium (DMEM) and DMEM: Ham's F12 (1:1) medium respectively, supplemented with fetal calf serum (FCS) (10% for HEK293 cells and 8% for CAD cells) and penicillin (60 mg/L) and streptomycin (100 mg/L). CAD cell differentiation was induced by removing FCS from the culturing media 24 h after transfection (Reiterer et al., 2008) . Lipofectamine 2000 was used to transfect the cells according to the manufacturer's protocol. Cultures of primary dorsal raphe neurons were generated as described (Montgomery et al., 2014) : briefly, newborn (P1) rats were sacrificed and brains were removed immediately. From the midbrain, dorsomedial sections of the dorsal raphe nucleus were dissected and digested in papain at 37°C for 20 min. The tissue was then triturated to dislodge the cells by pipetting the cells with increasingly smaller bore pipette tips. After trituration cells were centrifuged at 500×g for 4 min. The cell pellet was resuspended in neuronal medium. The neuronal cells were seeded afterwards onto a confluent layer of rat glial cells (obtained from cortex) grown on 15 mm glass coverslips. Glial-derived neurotrophic factor was added to 2 h after seeding to the culture. The proliferation of glial cells was inhibited by 5-fluorodeoxyuridine. After 7 days, the neurons were transfected with Lipofectamine 2000 according to the manufacturer's protocol.
Uptake assays -HEK293 cells (∼10 5 cells/well), which transiently expressed hSERT and hSERT-R607A, were seeded onto poly-D-lysinecoated 48-well plates. K M and V max values were measured by incubating the cells in Krebs-HEPES buffer containing [ 3 H]5-HT, the specific activity of which had been diluted progressively with unlabeled 5-HT to yield final concentrations 0.2, 1, 3, 10, 15 and 30 μM. The uptake reaction was performed at room temperature for 1 min; thereafter, the reaction was terminated by aspirating the medium followed by ice-cold washes of the cells with cold Krebs-HEPES buffer. Subsequently, the accumulated radioactivity was released by lysing the cells in 1% SDS; the lysate was mixed with scintillation cocktail and the radioactivity was measured. Uptake assays were performed 24, 48 and 72 h after transfection. Knock-down of SEC24C was done as described previously (Sucic et al., 2013) : HEK293 cells were transfected with a mixture of stealth RNA duplex oligoribonucleotides using lipofectamine RNAiMAX according to the manufacturer's instruction. Scrambled RNAs provided by the manufacturer was used as a negative control. After 48 h, cells were transfected with plasmids coding for hSERT and hSERT-R607A using Lipofectamine 2000. After an additional 24 h interval, cells (∼10 5 /well) were incubated with 0.2 μM [ 3 H]5-HT for 1 min. Nonspecific uptake was determined in parallel in the presence of 10 μM paroxetine. The reaction was stopped by washing with ice-cold Krebs-HEPES buffer and the samples were processed as outlined above.
Binding assays -HEK293 cells were transfected with plasmids encoding wild type hSERT and SERT-R607A. After 48 h, the cells were lysed, membranes (20 μg/reaction) were harvested and incubated as previously described (Sucic et al., 2010) with [ 3 H]imipramine in binding assay buffer (composition: 20 mM Tris-HCl, pH 7.4, 1 mM EDTA, 2 mM MgCl 2 , 120 mM NaCl, 3 mM KCl). Non-specific binding was determined in the presence of 10 μM paroxetine. The binding reaction (0.25 mL final volume) was performed for 20 min at 22°C. The reaction was terminated by rapid addition of ice-cold buffer and the membranes were collected onto polyethylenimine-coated glass fiber filters (Whatman GF/B). The radioactivity trapped on the filters was measured by liquid scintillation counting. In some experiments, HEK293 cells were co-transfected with plasmids encoding wild type hSERT or SERT-R607A and the dominant negative mutant Sar1A-H79G (El-Kasaby et al., 2010) or empty plasmid in a ratio of 1:6 to study binding transporters retained in the ER compartment. After 24 h, membranes were prepared from these cells and the binding assays done as outlined above.
Brain dissection and immunohistochemistry -Adult flies were anesthetized with CO 2 and transferred to 96% ethanol. Flies were washed A (R607A). CAD cells were co-transfected with MyrPalm-CFP to delineate the plasma membrane. The images are representative of three independent experiments with at least 10 images taken per condition. once in PBS before immersion into PBS. Brains were dissected in PBS and fixed in 2% paraformaldehyde in PBS for 1 h at room temperature. Primary raphe neurons were fixed in 3.7% paraformaldehyde for 20 min. Brains and raphe neurons were washed three times in PBS for 20 min. Samples were then transferred to blocking solution (0.3% Triton-X100 and 10% goat serum in PBS for fly brains and 0.2% saponin and 5% goat serum in PBS for primary neurons) for 1 h at room temperature. Samples were incubated in primary antibody overnight in blocking solution at 4°C on a shaker, subsequently washed three times for 20 min in PBS and incubated with secondary antibody in blocking solution. Samples were washed three times in PBS for 20 min. Subsequently, the brains were mounted with Vectashield ® (Vector Laboratory, Burlingame, CA).
Fluorescence microscopy -HEK293 and CAD cells (about 10 5 cells/ well) were seeded onto poly-D-lysine coated ibidi ® glass bottom chambers. Raphe neurons expressing tagged wild type or mutant SERT were seeded on 15 mm coverslips coated with poly-D-lysine (PDL). After 24 h, cells were imaged with a Zeiss LSM780 (630-fold overall magnification) and brains were imaged with a Leica SP5 II confocal laser scanning microscope (200-fold overall magnification) using oil immersion objectives. Z-stacks of the whole brain or of portions of the brain were taken at 1 or 1.5 μm intervals with a resolution of 512 × 512 pixels. Images were processed using Adobe Photoshop CS5.1and ImageJ. Anti-MAP2 antibody was used to label the dendrites of raphe neurons. The neurite extensions of single CSD neurons were labeled with GFP-tagged mCD8 by crossing CSD-Gal4 flies with flies harboring UAS-mCD8: GFP. In three instances, only a single neuron was labeled. This allowed for tracing the arborization of a single neuron by confocal imaging of serial sections (1.5 μm apart) followed by reconstruction using Imaris 9.2 FilamantTracer (Bitplane). Coexpression of MyrPalm-CFP (myristoylated and palmitoylated CFP) co-transfection was used to label plasma membranes of CAD cells.
Odor preference assay -The assay was performed as reported (Xu et al., 2016) with minor modifications. All experiments were performed at 25°C and 50% relative humidity. Briefly, 40 to 75 three to five-dayold male flies were placed in assay cage. The odor preference chamber (8.75 × 14.8 mm; 59-101, Flystuff, Genesee scientific, USA), roughly 1 L in volume, carried two odor traps (28 × 85 mm vials, SEM 470-162; Semadeni, Vienna, Austria) filled with 1.5 ml of 1:1 mixture of commercial mango (Rauch Fruchtsäfte, Austria) and orange (Rauch Fruchtsäfte, Austria) juice, one of which was supplemented with 5% ethanol (> 99%, VWR). Some flies were pretreated with the selective serotonin reuptake inhibitor (SSRI) citalopram to verify that odor perception was dependent on the function of SERT. These flies received food containing 3 mM citalopram for 48 h prior to their introduction into the assay cage. Flies were kept in the assay cage for 16 h. Thereafter, flies in each odor-trap were counted. A preference index (PI) was calculated by subtracting the number of flies in the odor-trap lacking alcohol from that in the odor-trap and dividing this difference by the total number of flies. A value ranging from > 0 to 1 was considered as the preference for ethanol. A preference index below 0 was indicative for preference for juice devoid of ethanol.
Results
Single point mutation in the RI-motif of SERT disrupts the interaction with SEC24C but does not impair folding
The C-terminus of SLC6 transporters harbors a conserved RI motif within an amphipathic α-helix, which recruits the COPII machinery component SEC24C for ER exit (Farhan et al., 2007; Sucic et al., 2011 Sucic et al., , 2013 . In SERT, disruption of this motif leads to a folding defect in the resulting SERT-607 RI 608 -AA mutant (El-Kasaby et al., 2010) . Similarly, the amphipathic nature of the C-terminal α-helix is required for folding of SERT (Koban et al., 2015) . However, the hydrophobic moment in the amphipathic C-terminal α-helix can be disrupted without affecting SEC24C-dependent ER export (Koban et al., 2015) . Based on this observation, it was conceivable that sole mutation of arginine 607 sufficed to disrupt the interaction with SEC24C. We tested this conjecture by expressing wild-type SERT or the mutant SERT-R
607
A transiently in HEK293 cells, which had been transfected with a mixture of siRNAs directed against SEC24C or scrambled siRNAs as a control (Fig. 1A ). Uptake of [ 3 H]5-HT by these transfected cells was measured after 24 h.
Because the transporter needs to reach the cell surface to support cellular uptake of substrate, uptake reflects the cell surface level of SERT. If hSERT-R
A did not rely on SEC24C to reach the cell surface, its surface levels were predicted to remain unaffected by depletion of SEC24C. This prediction was confirmed: the knockdown of SEC24C reduced 5-HT uptake by cells expressing wild type SERT, but it did not have any appreciable effect on that of cells expressing hSERT-R 607 A (Fig. 1A) . In the absence of any specific interaction with COPII machinery components, hSERT-R 607 A is predicted to eventually reach the cell surface via bulk flow, which is slower than the concentrative ERexport mediated by recruitment of SEC24C. Consequently, the cellular distribution of YFP-tagged hSERT-R 607 A and of YFP-WT-hSERT was visualized by using confocal microscopy in HEK293; images were acquired 24 h, 48 h and 72 h after transfection (Fig. 1B) . YFP-hSERT-R
A and YFP-WT-hSERT expression differed at 24 h: the mutant was predominantly confined within the cells; in contrast, wild type hSERT was targeted to the cell surface and very little fluorescence was observed inside the cells. Forty-eight and 72 h after transfection, YFPhSERT-R 607 A was largely localized at the cell surface (second and third right-hand panel in Fig. 1B and C) and was indistinguishable from wild type YFP-tagged hSERT (second left-hand panel in Fig. 1B ). CAD cells are derived from a neuroblastoma cell line; they can be differentiated into a neuron-like phenotype by serum withdrawal. We also expressed YFP-tagged wild type hSERT and hSERT-R A to the cell surface was delayed for the first 24 h. However, at 48 and 72 h, hSERT-R 607 A was also found on in the neurite extensions, where it colocalised with MyrPalm-CFP, which was used to delineate the plasma membrane (second and third row in Fig. 1C ). Folding defects impede the conformational transitions of the transporter required for supporting the transport cycle and hence result in lower substrate affinity and/or reduced affinity for radioligand inhibitors (Kasture et al., 2016; Asjad et al., 2017 Fig. 2A) . The binding affinity of hSERT-R 607 A (K D = 8.0 ± 2. 8 nM) was comparable to that of WT-hSERT (K D = 10.5 ± 4.5 nM) ( Fig. 2A). (ii) Similarly, substrate affinity was determined by incubating cells expressing hSERT-R 607 A and wild type-SERT with increasing concentrations of [ 3 H]5-HT (Fig. 2B) . The apparent substrate affinity was found to be comparable for hSERT-R 607 A (K M = 1.9 ± 0.8 μM) and wild type hSERT (K M = 3.3 ± 0.9 μM). Because the K M of substrate uptake and the affinity for inhibitor binding were comparable, we concluded that hSERT-R 607 A was fully functional and did not exhibit any major folding defect. Importantly, the ratio of V max (Fig. 2B) over B max ( Fig. 2A) was comparable for wild type hSERT and mutant hSERT-R 607 A indicating similar turnover numbers. This again suggests that hSERT-R 607 A undergoes the conformational cycle required for substrate translocation in a manner equivalent to wild type hSERT.
Substrate uptake reflects surface expression, because only transporters, which reach the plasma membrane can support influx of substrate. Consistent with the images shown in Fig. 1B and C, uptake of [ A uptake levels by the mutant significantly increased between 24 h and 48 h after transfection and then remained constant for an additional 24 h (right-hand set of bars in Fig. 2C ). In contrast, transport rates of wild type hSERT were comparable at all three time points (left-hand set of bars in Fig. 2C ). However, SERT-R607A did not reach the very same surface expression level as wild type SERT. We because a fraction of the ER-retained transporter is subject to degradation. The reduced maximum velocity of uptake V max can be accounted for by the delay in ER export: wild type hSERT accumulates to only about 50% of steady state levels, if its exit from the ER is impeded (El-Kasaby et al., 2010) . This is also evident from Fig. 2D , where we trapped wild type hSERT in the ER by coexpressing dominant negative SAR1A; after 24 h, membranes were prepared and the level of wild type SERT was detected by [3H]imipramine binding. In the presence of dominant negative SAR1A, wild type hSERT levels were similar to those of hSERT-R607A. In contrast, dominant negative SAR1A did not affect the levels of SERT-R607A in a statistically significant manner. We therefore conclude that the modest reduction in surface expression reflects degradation in the ER due to delayed export rather than a folding defect.
hSERT-R607A stays confined in the somatodendritic compartment of neurons in primary culture
Failure to recruit the COPII machinery precludes entry of GAT1 (Reiterer et al., 2008) and of SERT (Montgomery et al., 2014) into the axonal compartment; the transporters are confined to the somatodendritic compartment. Because hSERT-R 607 A did not rely on SEC24C for ER export (Fig. 1A) , it was predicted to remain confined to the somatodendritic compartment. This prediction was verified by expressing YFP-tagged wild type hSERT and mutant hSERT-R 607 A in serotonergic raphe neurons isolated from the brain of newborn rat pups (Fig. 3) . Neurons were stained with an anti-MAP2 antibody to label their dendritic compartment. In agreement with our previous findings (Montgomery et al., 2014) , wild type hSERT was found in MAP2-negative neurite extensions (marked with a white arrow in Fig. 3A ), but it also co-localized with MAP-2 immunostaining (Fig. 3A) . In contrast, hSERT-R 607 A was exclusively co-localized with MAP2 staining, indicating that the SERT-R 607 A mutant is enriched in the somatodendritic compartment (Fig. 3B) .
Differential distribution of dSERT-WT and dSERT-R599A in serotonergic neurons of drosophila
The findings obtained in primary neuronal culture confirmed earlier observations that SEC24-independent ER-export of SERT only allowed for somatodendritic targeting (Montgomery et al., 2014) . We validated the compartment-specific distribution of mutant SERT in vivo using (Fig. 4B , see also overlay in Fig. 4C ).
In Drosophila, the dSERT-R 599 A mutation in the conserved RI motif is equivalent of hSERT-R 607 A. The expression of UAS-YFP-WT-dSERT (Fig. 4D) and UAS-YFP-dSERT-R 599 A (Fig. 4E) by the TRH-GAL4 driver allowed for a direct comparison of wild type and the mutant transporter distribution in serotonergic neurons: dSERT-WT (Fig. 4D) showed a pattern of localization reminiscent of axonal synaptotagmin (Fig. 4B) . In contrast, the distribution of dSERT-R 599 A (Fig. 4E) recapitulated that of DenMark in most neuropil areas (Fig. 4A) , except for a distinct presynaptic region in the central brain (arrow in Fig. 4B) .
The subcellular distribution of wild type and mutant SERT is more readily appreciated and the resolution of individual compartments improved, if the analysis is limited to a single neuron per hemisphere and thus performed at single cell resolution. Accordingly, we observed the trafficking of SERT in the bilateral pair of "contralaterally projecting, serotonin-immunoreactive deuterocerebral (CSD) interneurons" (Roy et al., 2007; Xu et al., 2016; Zhang and Gaudry, 2016) . CSD-GAL4 (R37D04-GAL4) was used to drive the expression of the pertinent transgene in CSD neurons (Jenett et al., 2012) . The complex morphology of CSD neurons in the adult Drosophila brain, which include innervations of the antennal lobes (AL), the mushroom body (MB) and lateral horn (LH) neuropils as well as the superior medial protocerebrum (SMP) can be visualized by GFP-tagged mCD8 expression (Fig. 5A &B) . Interestingly, the somatodendritic compartment of CSD neurons encompasses the vast majority of these neural processes. This is evident from the widespread distribution of DenMark, which is in marked contrast to the discrete synaptotagmin-positive punctate labeling (Fig. 5C) . Fig. 5D highlights the distribution of DenMark and synaptotagmin in the antennal lobe (left hand images) and the lateral horn (right hand images). We visualized the subcellular targeting of wild type and mutant SERT in CSD neurons: the distribution of wild A/TRH-GAL4 (E). An antibody against neuronal cadherin (NCAD) was used to delineate the brain lobes (blue). The images were captured by confocal microscopy and compiled with imageJ by compressing a z-stack of confocal sections taken at a distance of 1.5 μm between each individual confocal plane (scale bar = 50 μm). Images are representative of at least 10 brains per condition. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) type transporter (Fig. 5E ) was far more widespread than that of dSERT-R 599 A (Fig. 5F ). This was particularly evident from the intense labeling of the antennal lobe with wild type SERT, where it accumulated in several glomeruli (e.g. VL1, marked by arrow in Fig. 5E and G, see also Fig. 6 ). This was absent in fly brains expressing dSERT-R 599 A ( Fig. 5F and H). In fact, the distribution of YFP-tagged dSERT-R 599 A was very similar to that of DenMark (cf. Fig. 5F and C) . Furthermore, we observed accumulation of wild type SERT (Fig. 5E and G) but not of dSERT-R 599 A ( Fig. 5F and H) in the antennal commissure. In addition, in this expression line, wild type SERT was also seen in axonal arborizations of SOG neurons within the lateral protocerebrum (white dotted circles, Fig. 5E ) and the midline (arrow head in Fig. 5E ) (Zhang and Gaudry, 2016 ). These were not visible in fly brains expressing dSERT-R 599 A (Fig. 5F) (Fig. 5F ). This difference again highlights the somatodendritic enrichment of dSERT-R 599 A in vivo.
We confirmed the restricted delivery of dSERT-R
599
A by co-expressing wild type and mutant transporter in CSD neurons. The coexpression of wild type YFP-dSERT and mutant mCherry-dSERT-R 599 A within the CSD neuron expression line (Fig. 6A-C and in sections shown in Fig. 6D&E) showed that the localization pattern of both proteins was not affected by their simultaneous synthesis in the same cell: wild type SERT was present in regions of the antennal lobe that were devoid of dSERT-R 599 A; wild type SERT was in particular enriched in the axons of the antennal commissure (Fig. 6D ) and in the glomeruli of the antennal lobe (shown for DA2, DL5, DM5, VA1d, VL1 in Fig. 6E ). In contrast, dSERT-R 599 A and wild type SERT colocalised in the protocerebral dendritic arborization (Fig. 6A) . Thus, taken together these data indicate a distinct distribution of dSERT-R 599 A in the adult fly brain, which is consistent with its confinement to the somatodendritic compartment and its absence in the presynaptic territory.
Compartment-specific SERT distribution affects drosophila odor preference
Flies harboring SERT-R 599 A allow for addressing the question, if the presence of SERT in the somatodendritic compartment is required to support neurotransmission and thus a physiologically relevant behavioral response. Wild type and mutant versions of dSERT were placed under the control of the GAL4-responsive upstream activating sequence and introduced into a background, where the endogenous dSERT gene had been disrupted by insertion of a transposable element after exon 3; the transposon encodes a splice acceptor site followed by three stop codons and a polyadenylation signal (Bellen et al., 2004; Hidalgo et al., 2017) . This results in termination after TM2 of the endogenous dSERT (Hidalgo et al., 2017) . The expression of GAL4 in this background was driven from the TRH promoter or from the CSD-specific promoter. Serotonergic neurons modulate olfaction. We examined the physiological activity of SERT within the somatodendritic compartment in a well-established behavioral paradigm for ethanol preference in Drosophila (Xu et al., 2016) : three to five-day old flies of the genotypes indicated in Fig. 7 were kept in an odor preference chamber for 16 h. Flies were provided with a choice between an odor trap containing or lacking 5% ethanol. Their preference was assessed by counting the flies trapped in both odor traps. The controls were the flies harboring the disrupted endogenous dSERT (referred to as SERT disrupted in Fig. 7 ) and wild type w 1118 flies with an intact endogenous dSERT gene, which showed a preference index of 0.2 and 0.55, respectively (left hand and right hand bar in Fig. 7A, respectively) . We confirmed that this difference was due to the disruption of the endogenous dSERT by two approaches: (i) Odor preference was restored to that seen in wild type w 1118 flies, if the wild type dSERT was re-expressed in the disrupted background by GAL4 under the control of the tryptophan hydroxylase promoter (TRH-GAL4) (second bar in Fig. 7A ).
(ii) Flies received food supplemented with the selective serotonin-reuptake inhibitor citalopram for 48 h prior to the behavioral assay. This pretreatment reduced the odor preference of wild type w 1118 flies (right hand bar in Fig. 7B ): the preference index of 0.2 was comparable to that of the flies harboring the disrupted endogenous dSERT. In contrast, administration of citalopram did not test that odor preference differed in all citalopram-treated flies but those solely harboring a transposon-disrupted SERT gene. This was the case (p-values ranging from 0.016 to < 0.0001). Subsequently, the data summarized in panel A were compared; these showed that all genotypes differed in a statistically significant manner (p < 0.001) from the flies harboring the transposon-disrupted SERT gene, that flies harboring TRH-GAL4/SERT RA and CSD-GAL4/wtSERT differed from all other flies (all p values < 0.001) and that flies harboring TRH-GAL4/wtSERT and CSD-GAL4/wtSERT were comparable to w1118 flies. Similar results were obtained, if the data summarized in B were analyzed by a Kruskal-Wallis test followed by Dunn's multiple comparison.
affect the preference index, if the endogenous dSERT was disrupted (cf. left hand bars in Fig. 7B and A) . Contrary to wild type dSERT, expression of dSERT-R 599 A in serotonergic neurons did not restore odor preference: in fact, in the dSERT-disrupted background, dSERT-R 599 A in serotonergic neurons abrogated odor preference, in which ethanol triggers an avoidance behavior (third bar labeled GAL4-TRH/SERT-RA in Fig. 7A ). This effect was accounted for by the transporter activity of dSERT-R 599 A, because administration of citalopram abrogated the switch in odor preference (cf. third bars in Fig. 7B and A) . CSD neurons play a crucial role in olfactory decision making by impinging on three levels of odorant cue processing, i.e. the antennal lobe, the mushroom body and the lateral horn (Fig. 5A) . CSD neurons also counteract the action of serotonergic neurons clustered in the protocerebral areas designated IP and LP1 (Xu et al., 2016) . Thus, we explored the distinct contribution of somatodendritic and axonal SERT to processing of odorant cues by expressing dSERT-R 599 A and wild type dSERT under the control of the CSD-GAL4 in the dSERT-disrupted background. Importantly, it was not the expression of wild type dSERT (fourth bar in Fig. 7A ) but that of dSERT-R 599 A (fifth bar in Fig. 7A ), which restored ethanol preference to the level seen in control w 1118 flies. In fact, the sole re-expression of wild type SERT in CSD neurons induced ethanol aversion. We again verified that the effects induced by reexpression of wild type dSERT and dSERT-R
599
A were contingent on the transporter activity of SERT by administering citalopram to the flies via their food: this pretreatment eliminated all differences in odor preference such that, in all instances, the preference index was similar to that seen in flies harboring a disrupted dSERT gene (Fig. 7B) . A pairwise comparison by a χ 2 -test confirmed that the preference observed in the absence and presence of citalopram differed in a statistically significant manner for all genotypes except for those flies, which solely harbored the transposon-disrupted dSERT gene (cf. panels A & B in Fig. 7 ). Taken together, these observations showed that the somatodendritically confined SERT-R 599 A sufficed to restore processing of odorant cues by CSD neurons.
Discussion
Somatodendritic monoamine transporters presumably serve to clear the extracellular space of their cognate neurotransmitters and to replenish somatodendritic vesicles in a manner analogous to presynaptic transporters. However, their physiological role is much less understood than that of transporters residing in axonal arborizations of the monoaminergic neurons. It has been appreciated that somatodendritic release of dopamine (Opazo et al., 2010 ), norepinephrine (de Kock et al., 2006 and serotonin (Huang et al., 2007; Colgan et al., 2012) occurs in the mammalian brain and that the underlying mechanisms differ from those regulating axonal release. In addition, somatodendritic DAT has been proposed to support dopamine release in the substantia nigra by switching into the reverse transport mode (Falkenburger et al., 2001) . It has, however, not been possible to examine, which biological responses, if any, depend on somatodendritic monoamine transporters. Here, we explored an approach to address this question by focusing on SERT, which is of relevance to mood disorders and pharmacotherapy. Three arguments support our conclusion that somatodendritic delivery of SERT is of physiological relevance. (i) Our experiments were designed to verify that a point mutation in the Cterminal motif, which is required for recruiting the cognate SEC24-isoform, i.e. mammalian SEC24C or Drosophila SEC24C/D, resulted in somatodendritic confinement of the resulting hSERT-R A placed under the control of TRH-GAL4 was predominantly enriched in the somatodendritic compartment, while wild type dSERT was readily delivered to axonal territories delineated by the presynaptic marker synaptotagmin. This was independently verified by using a GAL4 driver line, which labels a single serotonergic neuron per hemisphere, namely the CSD neuron. Even if wild type dSERT and dSERT-R 599 A were co-expressed, they were subject to segregated delivery: wild type dSERT was prominently enriched in the antennal commissure, a defined axonal region, which was devoid of dSERT-R 599 A. These observations are consistent with earlier findings that the axonal delivery of SERT (Montgomery et al., 2014) and of GAT1 (Reiterer et al., 2008 ) is contingent on COPII-dependent export from the ER. In fact, they rule out that this dependence arises from a cell culture artefact resulting from the absence of a trophic factor. Thus, dSERT-R 599 A is a valid experimental tool to address the role of somatodendritic SERT in vivo. (iii) The CSD neurons play a modulatory role in the olfactory circuit (Roy et al., 2007; Zhang and Gaudry, 2016; Coates et al., 2017; Xu et al., 2016) . In the antennal lobes, CSD neurons forms synapses with the local interneurons and projection neurons to modulate the odor response (Zhang and Gaudry, 2016; Coates et al., 2017) . In a SERT-deficient background, the targeted reexpression of dSERT-R 599 A and of wild type dSERT in CSD neurons allowed for examining the relative importance of axonal and somatodendritic SERT in processing odorant cues. The results were unequivocal: somatodendritic dSERT-R 599 A sufficed to restore ethanol preference to levels seen in wild type flies. In contrast, the presence of wild type SERT in both, the axonal and somatodendritic compartment, produced ethanol aversion. Flies harboring dSERT-R 599 A differ from those expressing wild type SERT by the absence of axonal transport activity. Because the presence of dSERT-R 599 A in CSD neurons sufficed to restore ethanol preference, it is safe to conclude that somatodendritic SERT supports ethanol attraction. SERT in the axonal compartment of CSD neurons specifies ethanol aversion. In the processing of olfactory cue, the effect of axonal SERT overrides the action of somatodendritic SERT. Thus, these findings demonstrate a distinct biological role of somatodendritic and axonal serotonin transport.
Expression of transgenes placed under the control of TRH-GAL4 is achieved in the vast majority -i.e. 75-100% -of serotonergic neurons (Alekseyenko et al., 2010) . The dichotomy of wild type dSERT and somatodendritically confined dSERT-R 599 A was recapitulated, if their expression was driven by TRH-GAL4: ethanol preference was restored by reexpression of wild type SERT but not of dSERT-R 599 A. For both, wild type SERT and dSERT-R 599 A, the odorant response differed after CSD-restricted and TRH-GAL4-mediated reexpression. This apparent discrepancy can be rationalized by taking into account that two additional clusters of serotonergic neurons in IP and LP1 impinge on the circuitry, which processes olfactory cues. Stimulation of IP and LP1 antagonize the action of CSD neurons (Xu et al., 2016) . While the precise hierarchy of the three serotonergic neurons in IP, LP1 and CSD is not known, it is clear.
That modulation of the ethanol preference depends on the activity of SERT: administration of the SSRI citalopram eliminated all changes in ethanol preference induced by forced expression of wild type dSERT or of dSERT-R 599 A, regardless of whether global reexpression or CSDrestricted expression was examined. Thus, our observations support the conclusion that axonal rather than somatodendritic serotonin transport in IP and LP1 serotonergic neurons is required to maintain ethanol preference.
Variations in SERT levels are thought to have an impact on the susceptibility of people for depression and anxiety: this is exemplified by a polymorphism in the promoter, where the short allele, which results in lower expression levels, is associated with a higher propensity of people to develop depression (Karg et al., 2011) and anxiety (Munafò et al., 2008) . It is not clear to which extent this increased susceptibility is affected by the levels of presynaptic and somatodendritic SERT. A bioinformatics study mined databases for possible disease markers, which were relevant for psychiatric disorders, i.e. schizophrenia, major depression and bipolar disease (Lee et al., 2011) : microarray data were collected from Brodmann area 10 of the prefrontal cortex of the patients. Genes, which differed from those of samples from control patients, were mapped onto protein-protein interaction networks extracted from several databases. This exercise showed that patients suffering from bipolar disorder have altered SEC24C levels; in fact, SEC24C was ranked first among 104 altered genes based on the error of probability (p = 0.00034; Lee et al., 2011) . It is worth noting that SERT could not be present in these transcripts: in the adult human brain, SERT is synthesized in the somata of the serotoninergic neurons of the raphe nuclei. Hence, the mRNA encoding SERT is not present in Brodmann area −10. Accordingly, SERT was not represented in the protein-protein interaction networks mapped by Lee et al. (2011) . Our findings highlight the importance of COPIIe dependent export of SERT from the ER in specifying axonal delivery of SERT in vivo. Loss of SEC24C is incompatible with normal brain development, because SeC24C-deficient neurons are prone to apoptosis (Wang et al., 2018) . However, the gene encoding SEC24C is highly polymorphic with e.g. 12 non-synonymous variants in the coding sequence (Sucic et al., 2011) . It is therefore plausible that variations in SEC24C have an impact on the relative levels of SERT in the axonal and the somatodendritic compartment. This may be of relevance in defining the susceptibility to mood disorders. Our observations show that in flies axonal and somatodendritic serotonin transport support distinct behavioral responses. Some expression of dSERT-R
599
A was also seen in the fan-shaped body, which -based on synaptotagmin -is an axonal territory of serotonergic neurons. This suggests that in some neurons, a fraction of dSERT-R 599 A can enter the axonal compartment. This is reminiscent of GAT1, where the corresponding mutant was also delivered at low levels to the axons (Reiterer et al., 2008) . The underlying mechanisms are not clear: possibly high levels of SEC24CD can overcome the effect of the point mutation in the SEC24-binding motif. This limitation does not detract from the major difference in the localization of wild type dSERT and dSERT-R 599 A and from the major difference in their effect on the processing of odorant cues. In depression, there is a delay in the onset of the therapeutic response to SSRIs and tricyclic antidepressants. A widely accepted model posits that inhibition of SERT leads to progressive desensitization of 5HT 1A -receptors, which act as autoreceptors in the dorsal raphe nuclei. The resulting decline in 5HT 1A -autoreceptor activity relieves the inhibition imposed by serotonin and thus allows for gradual recovery of the serotonergic neurons in the dorsal raphe such that their activity is restored (Garcia-Garcia et al., 2014) . This hypothetical sequence of events accounts for the delayed onset of the antidepressant action. It is not clear, if inhibition of SERT takes place on the presynaptic side, i.e. on recurrent collaterals of the dorsal raphe, or on the somatodendritic side. In fact, the number of serotonergic fibers in the dorsal raphe is low (Piñeyro and Blier, 1999) . Hence, it is conceivable that inhibition of somatodendritic SERT is more important to explain the antidepressant action than that of axonal SERT. The availability of a SERT variant, which is enriched in the somatodendritic compartment, allows for exploring this conjecture. It may also shed light on the role of SERT distribution in the development of mood disorders.
